EDP Sciences logo
Subscriber Authentication Point
Rechercher
Menu
Accueil Tous les numéros Volume 42 / Numéro 4 (Avril 2026) Med Sci (Paris), 42 4 (2026) 373-381 References
Open Access
Issue
Med Sci (Paris)
Volume 42, Number 4, Avril 2026
Page(s) 373 - 381
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2026056
Published online 24 avril 2026
  1. Cosgrove J, Hustin LSP, de Boer RJ, Perie L. Hematopoiesis in numbers. Trends Immunol 2021 ; 42 : 1100–12. [Google Scholar]
  2. Catlin SN, Busque L, Gale RE, et al. The replication rate of human hematopoietic stem cells in vivo. Blood 2011 ; 117 : 4460–6. [Google Scholar]
  3. Lee-Six H, Obro NF, Shepherd MS, et al. Population dynamics of normal human blood inferred from somatic mutations. Nature 2018 ; 561 : 473–8. [Google Scholar]
  4. Osorio FG, Rosendahl Huber A, Oka R, et al. Somatic mutations reveal lineage relationships and age-related mutagenesis in human hematopoiesis. Cell Rep 2018 ; 25 : 2308–16 e4. [Google Scholar]
  5. Olson OC, Kang YA, Passegue E. Normal hematopoiesis is a balancing act of self-renewal and regeneration. Cold Spring Harb Perspect Med 2020 ; 10. [Google Scholar]
  6. Busch K, Klapproth K, Barile M, et al. Fundamental properties of unperturbed haematopoiesis from stem cells in vivo. Nature 2015 ; 518 : 542–6. [Google Scholar]
  7. Bandyopadhyay S, Duffy MP, Ahn KJ, et al. Mapping the cellular biogeography of human bone marrow niches using single-cell transcriptomics and proteomic imaging. Cell 2024 ; 187 : 3120–40 e29. [Google Scholar]
  8. Ayhan S, Nemutlu E, Uckan Cetinkaya D, et al. Characterization of human bone marrow niches with metabolome and transcriptome profiling. J Cell Sci 2021 ; 134. [Google Scholar]
  9. Desterke C, Petit L, Sella N, et al. Inferring gene networks in bone marrow hematopoietic stem cell-supporting stromal niche populations. iScience 2020 ; 23 : 101222. [Google Scholar]
  10. Mendez-Ferrer S, Bonnet D, Steensma DP, et al. Bone marrow niches in haematological malignancies. Nat Rev Cancer 2020 ; 20 : 285–98. [Google Scholar]
  11. Lorenz E, Uphoff D, Reid TR, Shelton E. Modification of irradiation injury in mice and guinea pigs by bone marrow injections. J Natl Cancer Inst 1951 ; 12 : 197–201. [Google Scholar]
  12. Thomas ED, Lochte HL, Jr., Lu WC, Ferrebee JW. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med 1957 ; 257 : 491–6. [Google Scholar]
  13. Mathe G. [Problems presented to the hematologist by the treatment of subjects accidentally irradiated at high dose]. Rev Hematol 1960 ; 15 : 3–9. [Google Scholar]
  14. Robins MM, Noyes WD. Aplastic anemia treated with bone-marrow transfusion from an identical twin. N Engl J Med 1961 ; 265 : 974–9. [Google Scholar]
  15. Mathe G, Amiel JL, Schwarzenberg L, et al. Successful allogenic bone marrow transplantation in man: chimerism, induced specific tolerance and possible anti-leukemic effects. Blood 1965 ; 25 : 179–96. [Google Scholar]
  16. Malard F, Holler E, Sandmaier BM, et al. Acute graft-versus-host disease. Nat Rev Dis Primers 2023 ; 9 : 27. [Google Scholar]
  17. Degos L. Jean Dausset a scientific pioneer: intuition and creativity for the patients (1916-2009). Haematologica 2009 ; 94 : 1331–2. [Google Scholar]
  18. Jouet JP. La greffe de moelle osseuse, d’un siècle à l’autre. Med Sci (Paris) 2010 ; 26 : 447–8. [Google Scholar]
  19. Petersdorf EW. HLA structure and function in hematopoietic-cell transplantation. Best Pract Res Clin Haematol 2024 ; 37 : 101564. [Google Scholar]
  20. Aljurf M, Weisdorf D, Alfraih F, et al. Worldwide network for blood & marrow transplantation (WBMT) special article, challenges facing emerging alternate donor registries. Bone Marrow Transplant 2019 ; 54 : 1179–88. [Google Scholar]
  21. Scala S, Aiuti A. In vivo dynamics of human hematopoietic stem cells: novel concepts and future directions. Blood Adv 2019 ; 3 : 1916–24. [Google Scholar]
  22. Konturek-Ciesla A, Bryder D. Stem Cells, Hematopoiesis and lineage tracing: transplantation-centric views and beyond. Front Cell Dev Biol 2022 ; 10 : 903528. [Google Scholar]
  23. Calabria A, Spinozzi G, Cesana D, et al. Long-term lineage commitment in haematopoietic stem cell gene therapy. Nature 2024 ; 636 : 162–71. [Google Scholar]
  24. Spencer Chapman M, Wilk CM, Boettcher S, et al. Clonal dynamics after allogeneic haematopoietic cell transplantation. Nature 2024 ; 635 : 926–34. [Google Scholar]
  25. Wu C, Li B, Lu R, et al. Clonal tracking of rhesus macaque hematopoiesis highlights a distinct lineage origin for natural killer cells. Cell Stem Cell 2014 ; 14 : 486–99. [Google Scholar]
  26. Kim S, Kim N, Presson AP, et al. Dynamics of HSPC repopulation in nonhuman primates revealed by a decade-long clonal-tracking study. Cell Stem Cell 2014 ; 14 : 473–85. [Google Scholar]
  27. Koelle SJ, Espinoza DA, Wu C, et al. Quantitative stability of hematopoietic stem and progenitor cell clonal output in rhesus macaques receiving transplants. Blood 2017 ; 129 : 1448–57. [Google Scholar]
  28. Radtke S, Adair JE, Giese MA, et al. A distinct hematopoietic stem cell population for rapid multilineage engraftment in nonhuman primates. Sci Transl Med 2017 ; 9. [Google Scholar]
  29. Aiuti A, Biasco L, Scaramuzza S, et al. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science 2013 ; 341 : 1233151. [Google Scholar]
  30. Hacein-Bey-Abina S, Pai SY, Gaspar HB, et al. A modified gamma-retrovirus vector for X-linked severe combined immunodeficiency. N Engl J Med 2014 ; 371 : 1407–17. [Google Scholar]
  31. Hacein-Bey Abina S, Gaspar HB, Blondeau J, et al. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome. JAMA 2015 ; 313 : 1550–63. [Google Scholar]
  32. Biasco L, Pellin D, Scala S, et al. In vivo tracking of human hematopoiesis reveals patterns of clonal dynamics during early and steady-state reconstitution phases. Cell Stem Cell 2016 ; 19 : 107–19. [Google Scholar]
  33. Scala S, Basso-Ricci L, Dionisio F, et al. Dynamics of genetically engineered hematopoietic stem and progenitor cells after autologous transplantation in humans. Nat Med 2018 ; 24 : 1683–90. [Google Scholar]
  34. De Ravin SS, Liu S, Sweeney CL, et al. Lentivector cryptic splicing mediates increase in CD34+ clones expressing truncated HMGA2 in human X-linked severe combined immunodeficiency. Nat Commun 2022 ; 13 : 3710. [Google Scholar]
  35. Biffi A, Montini E, Lorioli L, et al. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science 2013 ; 341 : 1233158. [Google Scholar]
  36. Cavazzana M. Progrès de la thérapie génique dans les maladies génétiques du système hématopoïétique. Med Sci (Paris) 2022 ; 38 : 768–71. [Google Scholar]
  37. Chneiweiss H. 2023 : premiers succès et nouveaux enjeux de l’édition du génome en thérapeutique humaine. Med Sci (Paris) 2023 ; 39 : 589–90. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  38. Sessa M, Lorioli L, Fumagalli F, et al. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial. Lancet 2016 ; 388 : 476–87. [Google Scholar]
  39. Cartier N, Hacein-Bey-Abina S, Bartholomae CC, et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 2009 ; 326 : 818–23. [Google Scholar]
  40. Fumagalli F, Calbi V, Natali Sora MG, et al. Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access. Lancet 2022 ; 399 : 372–83. [Google Scholar]
  41. de Tocqueville S, Revy P. Sauvetage génétique somatique dans les maladies hématopoïétiques mendéliennes : du darwinisme cellulaire à la thérapie génique naturelle. Med Sci (Paris) 2025 ; 41 : 877–86. [Google Scholar]
  42. Mitchell E, Spencer Chapman M, Williams N, et al. Clonal dynamics of haematopoiesis across the human lifespan. Nature 2022 ; 606 : 343–50. [Google Scholar]
  43. Jaiswal S, Ebert BL. Clonal hematopoiesis in human aging and disease. Science 2019 ; 366. [Google Scholar]
  44. Oran B, Champlin RE, Wang F, et al. Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation. Leukemia 2022 ; 36 : 257–62. [Google Scholar]
  45. Gibson CJ, Kim HT, Zhao L, et al. Donor clonal hematopoiesis and recipient outcomes after transplantation. J Clin Oncol 2022 ; 40 : 189–201. [Google Scholar]
  46. Frick M, Chan W, Arends CM, et al. Role of donor clonal hematopoiesis in allogeneic hematopoietic stem-cell transplantation. J Clin Oncol 2019 ; 37 : 375–85. [Google Scholar]
  47. Oshima MU, Higgins J, Jenkins I, et al. Characterization of clonal dynamics using duplex sequencing in donor-recipient pairs decades after hematopoietic cell transplantation. Sci Transl Med 2024 ; 16 : eado5108. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.